The Estée Lauder Companies Inc.

(New York Stock Exchange)
Back to all articles
Bullish +75

Estée Lauder Companies takes minority stake in 111Skin

AI-generated analysis

📈 Estée Lauder Companies (ELC) has announced a minority investment in the luxury clinical skincare brand 111Skin.

👨‍⚕️ The 111Skin brand was co-founded by Dr Yannis Alexandrides and Eva Alexandrides, leveraging his experience as a plastic and reconstructive surgeon to create products that accelerate healing post-procedure.

🤝 The specific financial terms of the investment were not disclosed in the announcement.

💡 Stéphanie de La Faverie, President and CEO of ELC, stated that skincare is entering a new phase focused on procedures, longevity, and visible, treatment-inspired results.

✨ Dr. Alexandrides' background includes more than 35 years of surgical and aesthetic treatment experience which informs the brand's high-performance luxury skincare line.

🚀 ELC described this investment as a move grounded in consumer-centricity and transformative innovation to support 111Skin's continued global growth.

🔬 The partnership highlights ELC's ongoing focus on science-driven innovation and next-generation actives that reflect consumer desires for high-performance skincare.

🎉 Dr Yannis and Eva Alexandrides expressed excitement about partnering with ELC to unlock a new chapter and build on 111Skin's existing momentum.

🌐 Vanessa Goddevrind, CEO of 111Skin, looks forward to driving future growth together with the American beauty conglomerate.

💌 The founders shared a personal note via Instagram emphasizing that their commitment to care, precision, and dedication will remain unchanged despite the new investment.

🎯 111Skin's mission is to deliver surgically precise skincare with visible results through science and senses while preserving its distinctive approach.

📰 This announcement was accompanied by brief mentions of other beauty industry developments including ELC settling a data breach lawsuit, Westman Atelier securing $15 million in backing, L'Oréal investing in Hanni, and updates on the Puig-ELC merger situation.

Bullish Signals
  • Estée Lauder Companies (ELC) announced a minority investment in 111Skin, validating the luxury clinical skincare brand's market position.
  • 111Skin CEO Vanessa Goddevind expressed excitement about partnering with ELC to unlock an exciting new chapter and drive future growth together.
  • The founders view this partnership as an opportunity to build on their strong foundations while shaping the future of 111Skin with greater ambition.
  • ELC President and CEO Stéphane de La Faverie highlighted the significant opportunity to support the brand's continued global growth.
  • The investment reflects a consumer-centric approach and transformative innovation, aligning with ELC's 'Beauty Reimagined' vision.
  • 111Skin is praised for translating Dr. Alexandrides' more than 35 years of surgical experience into high-performance luxury skincare.
  • The brand maintains its commitment to delivering surgically precise skincare with visible results through science and senses.
Risk Factors
  • Terms of the minority investment by Estée Lauder Companies (ELC) in 111Skin were not disclosed, introducing uncertainty regarding the financial impact and strategic terms.
  • The article references a settlement reached by Estée Lauder Companies in a data breach class action lawsuit, indicating significant legal risks and potential reputational damage to the conglomerate.
  • Westman Atelier secured $15 million in new backing from L'Oréal's BOLD venture fund while competing for investment attention within the beauty sector.
  • Ongoing uncertainty surrounds the Estée Lauder Companies merger 'situation,' according to a recent update from Puig CEO, which could distract management and create strategic instability.
  • The investment is described as a minority stake, suggesting 111Skin remains largely independent but may lack sufficient capital depth for rapid large-scale expansion without further significant fundraising.
Full Analysis
Estée Lauder Companies (ELC) has announced a minority investment in 111Skin, marking the latest strategic move for the American beauty conglomerate to expand its portfolio with science-driven luxury brands. The clinical skincare brand is co-founded by Dr. Yannis Alexandrides and Eva Alexandrides, who established the company based on Dr. Alexandrides' experience as a plastic and reconstructive surgeon. Their original goal was to create products that would accelerate healing for patients following aesthetic procedures, eventually evolving into a full range of high-performance skincare inspired by in-clinic treatments. Stéphane de La Faverie, President and CEO of Estée Lauder Companies, highlighted the convergence of procedures, longevity, and beauty as key themes shaping the industry, noting that consumers now seek products with visible, treatment-inspired results. He described 111Skin as a prime example of this shift, leveraging Dr. Alexandrides' over 35 years of surgical and aesthetic experience into formulas built on clinical insight, next-generation actives, and proven efficacy. The investment is designed to support the brand's global growth while preserving its distinctive approach and consumer relevance under ELC’s “Beauty Reimagined” vision. The founders expressed gratitude for the partnership, viewing it as an opportunity to build on their strong foundations with greater ambition while maintaining their core mission of delivering surgically precise skincare. Dr. Yannis and Eva Alexandrides emphasized that despite the new chapter, their commitment to customers will not change, including the dedication to innovation, sensorial experiences, and visible results derived from science and senses. CEO Vanessa Goddevrind also voiced excitement about driving future growth together with Estée Lauder Companies. The specific terms of the investment remain undisclosed, but the move aligns with ELC's ongoing focus on science-driven innovation and consumer desire for high-performance skincare products. This acquisition joins other recent deals by Estée Lauder Companies, including investments in Westman Atelier and minority stakes in brands like 111Skin, while broader industry activity includes Westman Atelier securing $15 million in new backing and L’Oréal’s BOLD venture fund investing in Hanni. The announcement signals continued consolidation and strategic growth within the luxury skincare sector, with Estée Lauder Companies actively expanding its footprint through targeted minority investments rather than full acquisitions.